Steven Cohen Guardant Health, Inc. Call Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $5.14 Million - $8.07 Million	300,000 New	300,000 $6.19 Million
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $171,900 - $253,199	-7,500 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $190,800 - $448,350	7,500 New	7,500 $204,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.